Actively Recruiting

Age: 18Years +
All Genders
ID06878105

Evaluation of Fixed and Personal Assets for Patient Blood Management Implementation in Central Eastern European Countries in Practice

Led by Semmelweis University · Updated on 2025-03-14

2000

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

Sponsors

S

Semmelweis University

Lead Sponsor

C

CSL Behring

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to gather detailed information on the implementation of Patient Blood Management (PBM) programs in hospitals across Central Eastern European countries. It focuses on assessing the current status of PBM elements, including anemia management, bleeding management, and blood product usage, before and after PBM training. The study addresses identified gaps such as lack of protocols and inconsistent availability of point-of-care devices, aiming to improve patient care and optimize blood management. The study involves collecting hospital data through self-audits at two points: before PBM training and six months after training. These audits will evaluate hospital assets and practices related to the three pillars of PBM, including anemia diagnosis and management, blood-saving techniques, and transfusion triggers. Additionally, two one-week detailed "snapshot" periods will analyze perioperative patient care at the beginning and after six months. No experimental treatments are given; only routine medical data is recorded. Participants will be patients aged 18 and older undergoing elective surgeries with moderate to high bleeding risk. Data collected includes patient demographics, anemia and bleeding management details, anticoagulant therapy, transfusion needs, and postoperative outcomes. Researchers will compare blood product use and other indicators between the two audit periods to assess the impact of PBM training. The study's total duration includes baseline data collection, training, and follow-up audits six months later.

CONDITIONS

Brief Title

Patient Blood Management Implementation in CEE Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients above 18 years of age
  • Patients undergoing elective medium and high bleeding risk surgical intervention defined as moderate (<500 ml) and high (≥ 500 ml)
  • Patient consent
Not Eligible

You will not qualify if you...

  • No patient consent
  • Patients under 18 years of age
  • Pregnant patients
  • Surgery with a low risk of bleeding
  • The patient underwent emergency (non-elective) surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surveillance

Duration - 6 months

Participants who undergo routine care are observed for patient blood management indicators and perioperative blood product use before and after PBM training.

2 self-audit periods including two 1-week detailed analysis snapshots

Trial Site Locations

Total: 1 location

1

Semmelweis University

Budapest, Hungary, 1085

Actively Recruiting

Loading map...

Research Team

J

János Fazakas, Ass Prof

A

Anikó Smudla, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

129Xe Gas Exchange MRI to Visualize Cardiopulmonary Function

Interstitial Lung Disease

Actively Recruiting

1 location

A Phase 3 Randomized Trial Comparing Elritercept and Epoetin...

Myelodysplastic Syndrome

Actively Recruiting

146 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Allogeneic Blood Transfusion and Risk of Postoperative Complications in Patients with Mild and Moderate Anemia of Any Cause? A Retrospective Cohort Study in Total Revision Hip Surgery.

Henning Uden, Franziska Büttner, Christian von Heymann...

https://pubmed.ncbi.nlm.nih.gov/38314244

Preoperative Anemia and Iron Deficiency Screening, Evaluation and Management: Barrier Identification and Implementation Strategy Mapping.

Alana Delaforce, Jed Duff, Judy Munday...

https://pubmed.ncbi.nlm.nih.gov/33293819

Drivers for change: Western Australia Patient Blood Management Program (WA PBMP), World Health Assembly (WHA) and Advisory Committee on Blood Safety and Availability (ACBSA).

Shannon L Farmer, Simon C Towler, Michael F Leahy...

https://pubmed.ncbi.nlm.nih.gov/23590915

Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022.

Sibylle Kietaibl, Aamer Ahmed, Arash Afshari...

https://pubmed.ncbi.nlm.nih.gov/36855941